These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 29277675
1. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines. Visweswaran M, Arfuso F, Dilley RJ, Newsholme P, Dharmarajan A. Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675 [Abstract] [Full Text] [Related]
2. The Influence of Breast Tumour-Derived Factors and Wnt Antagonism on the Transformation of Adipose-Derived Mesenchymal Stem Cells into Tumour-Associated Fibroblasts. Visweswaran M, Keane KN, Arfuso F, Dilley RJ, Newsholme P, Dharmarajan A. Cancer Microenviron; 2018 Jun; 11(1):71-84. PubMed ID: 29637435 [Abstract] [Full Text] [Related]
3. Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway. Li M, Cai H, Yang Y, Zhang J, Sun K, Yan Y, Qu H, Wang W, Wang J, Duan X. Oncol Rep; 2016 Aug; 36(2):936-44. PubMed ID: 27277008 [Abstract] [Full Text] [Related]
4. Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro. Trivanović D, Nikolić S, Krstić J, Jauković A, Mojsilović S, Ilić V, Okić-Djordjević I, Santibanez JF, Jovčić G, Bugarski D. Cell Biol Int; 2014 Feb; 38(2):254-65. PubMed ID: 24155046 [Abstract] [Full Text] [Related]
5. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs. Mandal S, Arfuso F, Sethi G, Dharmarajan A, Warrier S. Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730 [Abstract] [Full Text] [Related]
6. EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration. Marastoni S, Andreuzzi E, Paulitti A, Colladel R, Pellicani R, Todaro F, Schiavinato A, Bonaldo P, Colombatti A, Mongiat M. J Pathol; 2014 Mar; 232(4):391-404. PubMed ID: 24374807 [Abstract] [Full Text] [Related]
7. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE. Breast Cancer Res; 2007 Mar; 9(5):R63. PubMed ID: 17897439 [Abstract] [Full Text] [Related]
8. Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer. Yeh WL, Tsai CF, Chen DR. Stem Cell Res Ther; 2017 Jul 27; 8(1):177. PubMed ID: 28750689 [Abstract] [Full Text] [Related]
9. Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro. Iser IC, Ceschini SM, Onzi GR, Bertoni AP, Lenz G, Wink MR. Mol Neurobiol; 2016 Dec 27; 53(10):7184-7199. PubMed ID: 26687184 [Abstract] [Full Text] [Related]
10. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. De Luca A, Lamura L, Gallo M, Maffia V, Normanno N. J Cell Biochem; 2012 Nov 27; 113(11):3363-70. PubMed ID: 22644871 [Abstract] [Full Text] [Related]
11. Cancer and normal adipose-derived mesenchymal stem cells (ASCs): Do they have differential effects on tumor and immune cells? Razmkhah M, Mansourabadi Z, Mohtasebi MS, Talei AR, Ghaderi A. Cell Biol Int; 2018 Mar 27; 42(3):334-343. PubMed ID: 29076586 [Abstract] [Full Text] [Related]
12. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells. Deshmukh A, Arfuso F, Newsholme P, Dharmarajan A. Int J Biochem Cell Biol; 2019 Apr 27; 109():23-32. PubMed ID: 30710752 [Abstract] [Full Text] [Related]
13. Influence of Mesenchymal Stem Cells Conditioned Media on Proliferation of Urinary Tract Cancer Cell Lines and Their Sensitivity to Ciprofloxacin. Maj M, Bajek A, Nalejska E, Porowinska D, Kloskowski T, Gackowska L, Drewa T. J Cell Biochem; 2017 Jun 27; 118(6):1361-1368. PubMed ID: 27873362 [Abstract] [Full Text] [Related]
14. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Devarajan E, Song YH, Krishnappa S, Alt E. Int J Cancer; 2012 Sep 01; 131(5):1023-31. PubMed ID: 22038895 [Abstract] [Full Text] [Related]
15. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and suppress the growth of MCF-7 human breast cancer cells. Ryu H, Oh JE, Rhee KJ, Baik SK, Kim J, Kang SJ, Sohn JH, Choi E, Shin HC, Kim YM, Kim HS, Bae KS, Eom YW. Cancer Lett; 2014 Oct 01; 352(2):220-7. PubMed ID: 25016057 [Abstract] [Full Text] [Related]
16. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway. Li T, Zhang C, Ding Y, Zhai W, Liu K, Bu F, Tu T, Sun L, Zhu W, Zhou F, Qi W, Hu J, Chen H, Sun X. Oncol Rep; 2015 Sep 01; 34(3):1469-77. PubMed ID: 26151310 [Abstract] [Full Text] [Related]
17. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. Wang W, Zhong W, Yuan J, Yan C, Hu S, Tong Y, Mao Y, Hu T, Zhang B, Song G. Oncotarget; 2015 Dec 08; 6(39):42276-89. PubMed ID: 26474277 [Abstract] [Full Text] [Related]
18. Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI. Lee MJ, Heo SC, Shin SH, Kwon YW, Do EK, Suh DS, Yoon MS, Kim JH. Int J Biochem Cell Biol; 2013 Aug 08; 45(8):1869-77. PubMed ID: 23735324 [Abstract] [Full Text] [Related]
19. Prospective dual role of mesenchymal stem cells in breast tumor microenvironment. Senst C, Nazari-Shafti T, Kruger S, Höner Zu Bentrup K, Dupin CL, Chaffin AE, Srivastav SK, Wörner PM, Abdel-Mageed AB, Alt EU, Izadpanah R. Breast Cancer Res Treat; 2013 Jan 08; 137(1):69-79. PubMed ID: 23143214 [Abstract] [Full Text] [Related]
20. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production. Escobar P, Bouclier C, Serret J, Bièche I, Brigitte M, Caicedo A, Sanchez E, Vacher S, Vignais ML, Bourin P, Geneviève D, Molina F, Jorgensen C, Lazennec G. Oncotarget; 2015 Oct 06; 6(30):29034-47. PubMed ID: 26362269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]